n-mBloc
-
Upload
flavio-guzman -
Category
Health & Medicine
-
view
1.309 -
download
0
Transcript of n-mBloc
![Page 1: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/1.jpg)
Neuromuscular Blockers
• Competitive Antagonists of the Nicotinic Receptor
e.g. curare (d-tubocurarine), vecuronium, pancuronium, atracurium, etc…
• Depolarizing Blockers
e.g. succinylcholine, decamethonium
![Page 2: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/2.jpg)
![Page 3: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/3.jpg)
![Page 4: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/4.jpg)
D-tubocurarine pancuronium
Vecuronium
Decamethonium
SuccinylcholineDepolarizing
Blockers
CompetitiveBlockers
![Page 5: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/5.jpg)
Neuromuscular blockers differ from each other in:
• Mechanism of action
• Duration of action
• Speed of onset and offset of action
• Selectivity of action and safety margin
• Adverse effects
![Page 6: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/6.jpg)
Agent Pharmacological
Properties
Onset time (min)
Duration
(min)
Elimination
Succinylcholine Ultrashort acting;
Depolarizing1-1.5 6-8
Plasma cholinesterase
D-tubocurarine Long duration;
Competitive4-6 80-120
Renal and liver
Atracurium Intermediate duration;
Competitive2-4 30-40
Plasma cholinesterase
Mivacurium Short duration;
Competitive2-4 12-18
Plasma cholinesterase
Pancuronium Long duration;
Competitive4-6 4-6
Renal and liver
Rocuronium Intermediate duration;
competitive1-2 1-2
Renal and liver
Classification of Blockers
![Page 7: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/7.jpg)
Muscle AP
Nerve AP
Left Leg Muscle Stimulation
Right Leg Nerve Stimulation
Right Leg Muscle Stimulation
Site of Action of d-Tubocurarine
![Page 8: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/8.jpg)
G: gallamine; TC: tubocurarine; NEO: neostigmine; S: succinylcholine.
Non-depolarizing Block
![Page 9: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/9.jpg)
Depolarizing Block
C10: decamethoniumTC: tubocurarineNEO: neostigmineS: succinylcholine
![Page 10: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/10.jpg)
Competitive Depolarizing
Effect of previous d-tubocurarine
Additive Antagonistic
Effect of previous decamethonium
None/antagonistic May be additive
Efect of cholinesterase inhibitors
Reverse No antagonism
Effect on motor end plate
Elevated threshold to Ach; no depolarization
Partial, persisting depolarization
Initial excitatory effect None Transient fasciculations
Effect of KCl or tetatnus on block
Transient reversal
No antagonism
Comparison of Competitive and Depolarizing Blocking Agents
![Page 11: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/11.jpg)
Dual Block by Depolarizing Agents
C10: decamethonium; NEO: neostigmine; TC: tubocurarine
NEO reversedthe blockadeby C10.
![Page 12: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/12.jpg)
Depolarizing Blocker
Competitive Blockade
Competitive Blocker
Noncompetitive Blockade
(desensitization)(electrogenic Na pump)
(direct channel block)
Changing Nature of Neuromuscular Blockade
![Page 13: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/13.jpg)
Sequence of Paralysis
Fingers, orbit (small muscles)
limbs Trunk neck
IntercostalsDiaphragm
Recovery in Reverse
![Page 14: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/14.jpg)
Other Effects of Neuromuscular Blockers
• Action at Autonomic Ganglia e.g. d-tubocurarine blocks, succinylcholine may stimulatenewer agents have less ganglionic effects
• Histamine Release e.g. d-tubocurarinebronchospasm, bronchial and salivary secretions
![Page 15: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/15.jpg)
Adverse Effects/Toxicity• Hypotension• Decreased tone and motility in GI tract• Depolarizing agents can cause increased K
efflux in patients with burns, trauma, or denervation and lead to hyperkalemia
• Prolonged apnea (many reasons, check for pseudochlinesterase genetic polymorphism)
• Malignant hyperthermia (succinylcholine + halothane especially)
• Sinus bradycardia/junctional rhythm (with succinylcholine)
![Page 16: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/16.jpg)
Systolic BP Systolic BP
% Change in Systolic BP with d-Tubocurarine as a Function of Dose and Depth of Anesthesia
Increasing Doseof d-tubocurarine
Increasing Depth(% Halothane)
0.25%
0.5%
0.75%
6 mg/m2
12 mg/m2
18 mg/m2
![Page 17: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/17.jpg)
Influence of Type of Anesthetic on Enhancement of Neuromuscular Blockade By d-Tubocurarine
![Page 18: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/18.jpg)
HR CO
SVR MAP
Hemodynamic Effects of d-Tubocurarine and Pancuronium
![Page 19: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/19.jpg)
![Page 20: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/20.jpg)
Drug Interactions
• Cholinesterase Inhibitors (antagonize competitive and enhance depolarizing)
• Inhalational Anesthetics (synergistic)
• Aminoglycoside Antibiotics (synergistic)
• Calcium Channel Blockers (synergistic)
![Page 21: n-mBloc](https://reader035.fdocuments.net/reader035/viewer/2022062514/55842b79d8b42a86478b4fed/html5/thumbnails/21.jpg)
Therapeutic Uses
• Adjuvant in surgical anesthesia
• Orthopedic procedures for alignment of fractures
• To facilitate intubations – use one with a short duration of action
• In electroshock treatment of psychiatric disorders